Barbados vs Grenada: The number of people with susceptibility test result for rifampicin
Barbados
0
in 2021
Grenada
0
in 2021
Barbados rank
146th
Grenada rank
146th
The number of people with susceptibility test result for rifampicin over time
- Barbados
- Grenada
How they compare
Barbados currently reports 0 against 0 in Grenada, a difference of 0.
The two have swapped places 2 times across 5 shared years of data; in 2017 it was Grenada ahead.
Barbados ranks 146th and Grenada ranks 146th of 155 countries.
Across the 2 decades both report, Barbados averaged higher in 1 and Grenada in 1.
Head to head by decade
| Decade | Barbados | Grenada | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0 | 0.6667 | 0.6667 | Grenada |
| 2020s | 1 | 0 | 1 | Barbados |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Barbados or Grenada?
- Barbados, at 0 against 0 in Grenada as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Barbados and Grenada?
- 0, with Barbados ahead.
- How many years of comparable data are there for Barbados and Grenada?
- 5 years are reported by both, from 2017 to 2021.
- How do Barbados and Grenada rank globally for the number of people with susceptibility test result for rifampicin?
- Barbados ranks 146th and Grenada ranks 146th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.